Terumo Cardiovascular

Terumo Cardiovascular is a leading player in the biotechnology, healthcare, and manufacturing industries. Established in 1999, it is headquartered in the United States. The company's mission, encapsulated in the slogan "Our mission is to work as a team to save one more life, today and every day.", revolves around manufacturing and marketing medical devices for cardiac and vascular surgery, with a specialized focus on cardiopulmonary bypass and intra-operative monitoring.

As a subsidiary of the esteemed Terumo Corporation of Japan, which has a legacy of almost 100 years in the medical technology space, Terumo Cardiovascular benefits from being part of a global leader in healthcare. Operating extensively, with more than 25,000 associates worldwide, the company is dedicated to providing innovative medical solutions in over 160 countries and regions.

In line with its parent company's commitment to "Contributing to Society through Healthcare," Terumo Corporation has diversified its business portfolio, ranging from vascular intervention and cardio-surgical solutions to blood transfusion and cell therapy technology, and essential medical products for daily clinical practice. The company constantly strives to provide value to patients, medical professionals, and society in general.

However, it is worthy of mention that the last investment and the investors involved are currently unavailable. Nonetheless, with its strong corporate backing and strategic focus, Terumo Cardiovascular stands as a noteworthy player in the medical device space, with potential opportunities for venture capital investment.